Assessment of the Safety and Efficiency of a Preperitoneal Continuous Infusion Using Bupivacaine after Abdominal Laparotomy in Digestive Carcinology

<div>Curves of venous plasma concentrations of bupivacaine as a function of time after infiltration of the wound with 5 ml/h of bupivacaine for 48 hours in thirty patients in the bupivacaine group. Each curve shows one patient.</div>

Anesthesiology Research and Practice

fig5

Figure 5

Figure 5: Assessment of the Safety and Efficiency of a Preperitoneal Continuous Infusion Using Bupivacaine after Abdominal Laparotomy in Digestive Carcinology 

Figure 5 | Assessment of the Safety and Efficiency of a Preperitoneal Continuous Infusion Using Bupivacaine after Abdominal Laparotomy in Digestive Carcinology 